Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes

被引:23
作者
Pittenger, GL
Malik, RA
Burcus, N
Boulton, AJ
Vinik, AI
机构
[1] Strelitz Diabet Inst, Dept Internal Med, Norfolk, VA USA
[2] Eastern Virginia Med Sch, Dept Pathol Anat & Neurobiol, Norfolk, VA 23501 USA
[3] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
关键词
D O I
10.2337/diacare.22.11.1839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Neuropathy is the most common complication of diabetes, and toxic serum factors may contribute to its genesis. RESEARCH DESIGN AND METHODS - We assessed neurotoxicity in the serum of 39 diabetic patients and correlated it with clinical measures of somatic and autonomic nerve fiber damage. Sera were applied to N1E-115 and VSC4.1 neuroblastoma cells in vitro as models of sensory/autonomic (S/A) and motor neurons, respectively. Neurotoxicity was measured as either complete or near-complete cell death (highly toxic), inhibited cell growth (moderately toxic), or normal cell proliferation (nontoxic) compared with pooled human serum controls during culture over 4 days. RESULTS - There was an inverse correlation between neurotoxicity and vibration perception threshold (P < 0.01). Age (P < 0.02), duration of diabetes (P < 0.02), and HbA(1c) (P < 0.03) correlated with neurotoxicity, suggesting that glycation may contribute to cytotoxicity in this model. S/A neurotoxicity occurred more frequently in the sera of patients with type 1 (19 of 25) than type 2 (5 of 14) diabetes (P < 0.02). None of the sera from either type 1 or type 2 diabetic patients displayed neurotoxicity on VSC4.1 cells, whereas sera from patients with motor neuropathy were highly toxic. CONCLUSIONS - These studies indicate that there is a relationship between the specific nerve fiber dysfunction in the patient and the type of neuronal cell killed, not only for diabetic neuropathy but also for known forms of autoimmune neuropathies. Such toxic factors may contribute to diabetic neuropathy by acting in concert with hyperglycemia to damage sensory/autonomic neurons.
引用
收藏
页码:1839 / 1844
页数:6
相关论文
共 31 条
[1]   ANTI-ADRENAL MEDULLARY ANTIBODIES IN IDDM SUBJECTS AND SUBJECTS AT HIGH-RISK OF DEVELOPING IDDM [J].
BROWN, FM ;
KAMALESH, M ;
ADRI, MNS ;
RABINOWE, SL .
DIABETES CARE, 1988, 11 (01) :30-33
[2]   DIFFERENT EFFECTS OF DURATION ON PREVALENCE OF ANTI-ADRENAL MEDULLARY AND PANCREATIC-ISLET CELL ANTIBODIES IN TYPE-I DIABETES-MELLITUS [J].
BROWN, FM ;
VINIK, AI ;
GANDA, OP ;
ADRI, MNS ;
RABINOWE, SL .
HORMONE AND METABOLIC RESEARCH, 1989, 21 (08) :434-437
[3]   ANTI-SYMPATHETIC NERVOUS-SYSTEM AUTOANTIBODIES - DIMINISHED CATECHOLAMINES WITH ORTHOSTASIS [J].
BROWN, FM ;
BRINK, SJ ;
FREEMAN, R ;
RABINOWE, SL .
DIABETES, 1989, 38 (07) :938-941
[4]  
Diabet Control Complications Trial Res Grp, 1998, DIABETOLOGIA, V41, P416
[5]  
GREENE DA, 1989, CRIT REV NEUROBIOL, V5, P143
[6]   DIABETIC AUTONOMIC NEUROPATHY AND IRITIS - AN ASSOCIATION SUGGESTING AN IMMUNOLOGICAL CAUSE [J].
GUY, RJC ;
RICHARDS, F ;
EDMONDS, ME ;
WATKINS, PJ .
BRITISH MEDICAL JOURNAL, 1984, 289 (6441) :343-345
[7]   The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy [J].
Jude, EB ;
Abbott, CA ;
Young, MJ ;
Anderson, SG ;
Douglas, JT ;
Boulton, AJM .
DIABETOLOGIA, 1998, 41 (03) :330-336
[8]   INCREASED ACTIVITY OF L-TYPE CA2+ CHANNELS EXPOSED TO SERUM FROM PATIENTS WITH TYPE-I DIABETES [J].
JUNTTIBERGGREN, L ;
LARSSON, O ;
RORSMAN, P ;
AMMALA, C ;
BOKVIST, K ;
WAHLANDER, K ;
NICOTERA, P ;
DYPBUKT, J ;
ORRENIUS, S ;
HALLBERG, A ;
BERGGREN, PO .
SCIENCE, 1993, 261 (5117) :86-90
[9]   AMYOTROPHIC-LATERAL-SCLEROSIS PATIENT ANTIBODIES LABEL CA2+ CHANNEL ALPHA(1) SUBUNIT [J].
KIMURA, F ;
SMITH, RG ;
DELBONO, O ;
NYORMOI, O ;
SCHNEIDER, T ;
NASTAINCZYK, W ;
HOFMANN, F ;
STEFANI, E ;
APPEL, SH .
ANNALS OF NEUROLOGY, 1994, 35 (02) :164-171
[10]   ISOLATION, CHARACTERIZATION, AND METABOLISM OF THE GLYCATED AND NONGLYCATED SUBFRACTIONS OF LOW-DENSITY LIPOPROTEINS ISOLATED FROM TYPE-I DIABETIC-PATIENTS AND NONDIABETIC SUBJECTS [J].
KLEIN, RL ;
LAIMINS, M ;
LOPESVIRELLA, MF .
DIABETES, 1995, 44 (09) :1093-1098